Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,719 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Terminated

Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

NCT06161116

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Medvin Clinical Research - Metyas ( Site 0128) Covina, California, United States
  • UCSD - Altman Clinical and Translational Research Institute (ACTRI)-Center for Innovative Therapy ( Site 0110) La Jolla, California, United States
  • Arthritis & Osteoporosis Medical Center - La Palma ( Site 0108) La Palma, California, United States
  • Medvin Clinical Research - Tujunga ( Site 0127) Tujunga, California, United States
View all 127 locations
View Trial Details
Terminated

TruGraf Liver Gene Expression Serial Test

NCT06061341

Conditions
Autoimmune Diseases, Autoimmune Hepatitis, Autoimmune Liver Disease, +19 more
Locations
  • Washington University and Barnes Jewish Hospital St Louis, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Terminated

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +13 more
Locations
  • Investigative Site 118 Birmingham, Alabama, United States
  • Investigative Site 108 Little Rock, Arkansas, United States
  • Investigative Site 105 San Diego, California, United States
  • Investigative Site 116 Tampa, Florida, United States
View all 19 locations
View Trial Details
Terminated

A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT

NCT03368664

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Investigational Site Number : 2500001 Le Kremlin-Bicêtre, France
  • Investigational Site Number : 2500002 Strasbourg, France
  • Investigational Site Number : 3800004 Naples, Napoli, Italy
  • Investigational Site Number : 3800005 Cagliari, Italy
View all 13 locations
View Trial Details
Suspended

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

NCT04870944

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 35 locations
View Trial Details
Suspended

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT06179888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 74 locations
View Trial Details

Related conditions